Ann Marie Navar MD PhD, FACC, FAHA, FASCP

PubMed

• SBDH-Reader: a large language model-powered method for extracting social and behavioral determinants of health from clinical notes.
  Zifan Gu, Lesi He, Awais Naeem, Pui Man Chan, Asim Mohamed
  Journal of the American Medical Informatics Association. 2025-07-28
• Rationale and design of the REMBRANDT trial: A phase 3 study to evaluate the effect of obicetrapib/ezetimibe on coronary plaque characteristics.
  Cian P McCarthy, Christie M Ballantyne, Ron Blankstein, Matthew J Budoff, Marc Ditmarsch
  American Heart Journal. 2025-07-17
• Management Patterns and Outcomes of Invasive Mechanical Ventilation in Patients With Cardiogenic Shock.
  Christopher S Grubb, Grant Tucker, Neda Bionghi, Catherine Chen, Bethany L Lussier
  JACC. Advances. 2025-07-03

Journal Articles

• Choosing an Initial Therapeutic Approach for Hypertension—Time for a Fixed-Dose Combination First?  
  Ann Marie Navar, Thomas J Wang, JAMA Cardiology
• Heroism in the Face of the COVID-19 Pandemic  
  Ajay J Kirtane, Ann Marie Navar, JAMA Cardiology
• Moving Beyond Regression Techniques in Cardiovascular Risk Prediction: Applying Machine Learning to Address Analytic Challenges  
  Ann Navar, MD, European Heart Journal

Abstracts/Posters

• [Board 414] Triglycerides as a Risk Factor For Coronary Heart Disease: What Measure and What Cutoff?
  Ann Navar, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019

Lectures

• Deep Dive II 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019